Momentum Life Sciences Named a 2026 PM360 Trailblazer Awards Finalist in Two Categories
Momentum Life Sciences has been named a finalist in two categories of the 2026 PM360 Trailblazer Awards, recognizing innovative work and impact across the life sciences industry.
This year, Momentum is recognized for two programs designed to support patients and healthcare professionals at important points throughout the treatment journey:
- HCP Education — YEZTUGO® (lenacapavir) Nurse Educator Field Program
Recognized for an HCP education program supporting the launch of a first-in-class, twice-yearly injectable for HIV prevention. - Persistence/Adherence — Nurse Navigator Patient Support Program
Recognized for a nurse-led patient support program providing ongoing education and engagement for people living with rare and refractory epilepsy.
Both finalist programs reflect Momentum’s focus on expert-led engagement designed around the needs of patients, healthcare professionals and the therapies they navigate.
The 2026 PM360 Trailblazer Award winners will be announced at the Trailblazer Awards Gala on September 29 in New York City.

Latest posts
Meeting Patients Where They Are: Why Trust Matters
Patient support programs have steadily expanded , adding more channels, more touchpoints, and more digital tools designed to keep patients informed and on therapy. But the experience patients describe often tells a different story. Despite the investments in personalization tools, channel optimization, and deep analytics around engagement, many patients report feeling less connected to their support program over time, not more.
The Front-End Shift: Prioritizing Dedicated Patient Engagement Beyond Hub and Specialty Pharmacy
Much of today's patient support is structured around the prescription — access, fulfillment, logistics. But some of the moments that most influence whether a patient initiates, adheres, and persists tend to happen somewhere else entirely: in the space between the prescription and the patient.





